Cardiothoracic Surgery
MD, Professor of Surgery, Harvard Medical School, Director of Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital, Associate Chief of Surgery, Dana Farber Cancer Institute
Dr. Scott J. Swanson is a thoracic surgeon and director of Minimally Invasive Thoracic Surgery at Brigham and Women’s Hospital. He is chief surgical officer of Dana-Farber Brigham Cancer Center and is a professor of surgery at Harvard Medical School. Dr. Swanson received his medical degree from Harvard Medical School and completed his general and cardiothoracic surgical residencies at the Brigham. He completed a fellowship in vascular biology at Harvard Medical School and a thoracic oncology fellowship at the Brigham. Dr. Swanson is board certified in surgery and thoracic surgery. He has been listed as one of America’s Top Doctors by Castle Connolly and named a top thoracic surgeon by Boston Magazine. Dr. Swanson’s clinical interests include minimally invasive thoracic surgery and lung cancer. His research is focused on better understanding early stage lung cancer, its biologic fingerprint and clinical behavior.
Selected publications from PubMed
Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.
Pennathur A, Lanuti M, Merritt RE, Wolf A, Keshavarz H, Loo BW, Suh RD, Mak RH, Brunelli A, Criner GJ, Mazzone PJ, Walsh G, Liptay M, Wafford QE, Murthy S, Marshall MB, Tong B, Pettiford B, Rocco G, Luketich J, Schuchert MJ, Varghese TK, D'Amico TA, Swanson SJ, AATS Clinical Practice Standards Committee: Thoracic Surgery
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):106-113 doi: 10.1053/j.semtcvs.2024.11.003.
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.
Wolf A, Loo BW, Mak RH, Liptay M, Pettiford B, Rocco G, Lanuti M, Merritt RE, Keshavarz H, Suh RD, Brunelli A, Criner GJ, Mazzone PJ, Walsh G, Wafford QE, Murthy S, Marshall MB, Tong B, Luketich J, Schuchert MJ, Varghese TK, D'Amico TA, Pennathur A, Swanson SJ, AATS Clinical Practice Standards Committee: Thoracic Surgery
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):89-98 doi: 10.1053/j.semtcvs.2024.10.005.
Systematic Review of Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.
Merritt RE, Brunelli A, Walsh G, Murthy S, Schuchert MJ, Varghese TK, Lanuti M, Wolf A, Keshavarz H, Loo BW, Suh RD, Mak RH, Criner GJ, Mazzone PJ, Liptay M, Wafford QE, Marshall MB, Tong B, Pettiford B, Rocco G, Luketich J, D'Amico TA, Swanson SJ, Pennathur A, AATS Clinical Practice Standards Committee: Thoracic Surgery
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):99-105 doi: 10.1053/j.semtcvs.2024.11.002.
Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.
Pennathur A, Lanuti M, Merritt RE, Wolf A, Keshavarz H, Loo BW, Suh RD, Mak RH, Brunelli A, Criner GJ, Mazzone PJ, Walsh G, Liptay M, Wafford QE, Murthy S, Marshall MB, Tong B, Pettiford B, Rocco G, Luketich J, Schuchert MJ, Varghese TK, D'Amico TA, Swanson SJ, AATS Clinical Practice Standards Committee: Thoracic Surgery
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):67-74 doi: 10.1053/j.semtcvs.2024.10.002.
Treatment Selection for the High-Risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-Guided Thermal Ablation?
Pennathur A, Lanuti M, Merritt RE, Wolf A, Keshavarz H, Loo BW, Suh RD, Mak RH, Brunelli A, Criner GJ, Mazzone PJ, Walsh G, Liptay M, Wafford QE, Murthy S, Marshall MB, Tong B, Pettiford B, Rocco G, Luketich J, Schuchert MJ, Varghese TK, D'Amico TA, Swanson SJ, AATS Clinical Practice Standards Committee: Thoracic Surgery
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):114-121 doi: 10.1053/j.semtcvs.2024.10.004.
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on advances in thoracic cancer surgery. This event features medical presentations, operation videos, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jul 2023
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on anatomical partial lobectomy. This event features medical presentations, operation videos, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jul 2023
In recent years, China's thoracic surgery technology has developed rapidly, entering the era of minimal invasive precision and committed to promoting the standardization and precision of thoracic surgery. AIS specially invites the leading faculties in the field of thoracic surgery from China, Italy and the United States to share academic expertise on the Resection of Lingual Segment of Left Upper Lung surgery.
With Johnson & Johnson MedTech
Published
Dec 2022
Dr. Piergiorgio Solli, Dr. David Healy, Dr. Lorenzo Rosso, Dr. Robert J Cerfolio, Dr. Marco Scarci, Dr. Scott J. Swanson, Dr. Lunxu Liu, Dr. Haiquan Chen, Dr. Ke-Neng Chen present the congress Global Perspectives: Thoracic Surgery on the Frontline of COVID-19.
With Johnson & Johnson MedTech
Published
Apr 2020
Help your network discover Dr. Scott J. Swanson's clinical expertise.
